16110-247 : Seysara 150 mg Oral Tablet, Coated


NDC16110-247
Labeler: Almirall, LLC
Product Type: Human Prescription Drug
Drug Name:  Seysara
Dosage Form: Oral Tablet, Coated
Application #: NDA209521
Rev. Date: 


Appearance:


Markings: S150
Shapes:  Capsule
Colors:  Yellow
Size (mm): 17
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 16110-247-30: 30 TABLET, COATED IN 1 BOTTLE (16110‑247‑30)

Active Ingredients:

  • Sarecycline Hydrochloride

Dosage Strength:

  • 150 mg

Inactive Ingredients:

  • Microcrystalline Cellulose
  • Povidone, Unspecified
  • Sodium Starch Glycolate Type a Potato
  • Sodium Stearyl Fumarate
  • D&c Yellow No. 10
  • Ferric Oxide Yellow
  • Methacrylic Acid - Ethyl Acrylate Copolymer (1:1) Type a
  • Polyethylene Glycol, Unspecified
  • Polyvinyl Alcohol, Unspecified
  • Sodium Bicarbonate
  • Talc
  • Titanium Dioxide /

Pharmaceutical Classes:

  • Tetracycline-class Drug [EPC]
  • P-Glycoprotein Inhibitors [MoA]
  • Tetracyclines [CS]

Related Products:

Based on records with the same trade name.
  • 16110-245 Seysara 60 mg Oral Tablet, Coated by Almirall, LLC
  • 16110-246 Seysara 100 mg Oral Tablet, Coated by Almirall, LLC
  • 0023-6245 Seysara 60 mg Oral Tablet by Allergan, Inc.
  • 0023-6246 Seysara 100 mg Oral Tablet by Allergan, Inc.
  • 0023-6247 Seysara 150 mg Oral Tablet by Allergan, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 16110-247 QR Code

< Prev: 16110-246Next: 16110-259 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.